Does Spaceflight Increase the Chance of Female Astronauts Developing Uterine Cancer? by Mosa, Areej
East Tennessee State University
Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations Student Works
5-2018
Does Spaceflight Increase the Chance of Female
Astronauts Developing Uterine Cancer?
Areej Mosa
East Tennessee State University
Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Biology Commons
This Thesis - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State University. It
has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East Tennessee State
University. For more information, please contact digilib@etsu.edu.
Recommended Citation
Mosa, Areej, "Does Spaceflight Increase the Chance of Female Astronauts Developing Uterine Cancer?" (2018). Electronic Theses and
Dissertations. Paper 3361. https://dc.etsu.edu/etd/3361
  
Does Spaceflight Increase the Chance of Female Astronauts Developing Uterine Cancer?   
_____________________  
  
  
A thesis  
  
presented to  
  
the faculty of the Department of Biological Sciences  
  
East Tennessee State University  
  
  
In partial fulfillment  
  
of the requirements for the degree  
  
Master of Science in Biology  
  
  
_____________________  
  
  
by  
  
Areej Mosa 
  
May 2018  
  
  
_____________________  
  
  
Allan D. Forsman, PhD, Chair  
  
James Ross Stewart, PhD  
  
Alok Agrawal, PhD  
  
  
Keywords: spaceflights, uterine cancer, microgravity, radiation, and female astronauts 
2  
  
ABSTRACT 
  
Does Spaceflight Increase the Chance of Female Astronauts Developing Uterine Cancer?   
 
by  
  
Areej Mosa 
 
One of the main questions put forth by NASA and the European Space Agency (ESA) is whether 
or not an organism, especially mankind, can complete an entire life cycle in space. With this in 
mind, it is essential to study the effect of spaceflight on reproductive tissues. Using simulated 
microgravity techniques and whole-body radiation we sought to determine if females subjected 
to a simulated spaceflight environment have increased incidences of uterine cancer. Uterine 
tissue from mice subjected to simulated spaceflight was analyzed using immunohistochemical 
staining and western blot analysis. Two pathways commonly activated in cancer were 
investigated. Additionally, the uterine tissue was evaluated for gross morphological changes 
using standard histological staining. The findings of this study indicate that none of the treatment 
parameters used to simulate the spaceflight environment were found to induce uterine cancer. 
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CHAPTER 1 
INTRODUCTION 
One of the main questions put forth by NASA and the European Space Agency (ESA) is 
whether or not an organism, especially mankind, can complete an entire life cycle in space. 
With this in mind, it is essential to study the effect of spaceflight on reproductive tissues as one 
of the significant human organs. There are two factors involved with spaceflight that are 
dramatically different from conditions on Earth. First, the spaceflight environment is one of 
very low gravity (microgravity). Second, the spaceflight environment is one of relatively high 
levels of radiation (galactic cosmic radiation) compared to that on Earth. Spaceflight has been 
shown to have effects on many different tissues of the body (Williams et al. 2009). It is 
unknown whether those effects are due to the microgravity of spaceflight, the elevated levels of 
radiation, or a combination of the two.  
The primary physiological responses of vertebrates to spaceﬂight microgravity include 
ﬂuid shifts, cardiovascular problems, musculoskeletal unloading, disturbance of senses, and 
immunity dysregulation (Pace 1977; Vernikos 1996). 
 
Effect of Microgravity on the Cardiovascular System 
Compromised cardiovascular functions have been reported in astronauts during 
spaceflight. Orthostatic intolerance and reduced aerobic capacity seemed to be the most pressing 
of cardiovascular issues faced by astronauts (Convertino 2009). Orthostatic intolerance is a 
serious health problem that faces astronauts during re-entry into earth’s atmosphere and 
immediately after landing. Orthostatic intolerance is characterized by inability to remain in 
upright posture while maintaining adequate blood supply to the brain. One hypothesis that can 
describe these changes is cephalad fluid shift (Charles and Lathers 1991). Normally on earth and 
under the effect of 1g gravity, the hydrostatic pressure is higher in the lower body compartment 
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than the upper body. This is because the fluid in the upper part of the body exerts a pressure on 
the fluid in the lower part of the body. Venous return is the volume of blood in systemic veins 
that flow back to the heart. In a standing position, the return of venous blood to the upper part of 
the body is challenged. This is because the blood flow has to overcome the effect of gravity. The 
skeletal muscle pump helps force the blood toward heart. The peripheral veins in the legs have 
one-way valves that do not allow backflow of blood away from the heart. These valves 
counteract the gravitational pull and prevent backflow of blood when standing. Upon entering 
the space environment, the skeletal muscle pump is still pushing the blood in a cephalad 
direction, but there is no resistance to this blood flow because there is no gravitational force 
pulling the blood back down. This fluid shift toward the head (cephalad) is called cephalad fluid 
shift (Drake et al. 2015).   
Microgravity initiates a fluid shift, due to absence of hydrostatic pressure gradients, with 
blood and other fluids moving from lower limbs toward head and thorax. Facial swelling is a 
common change in astronauts due to high blood supply in head region. During spaceflight, the 
volume in lower limbs is reduced by 10% compared with preflight (Leach et al. 1991).  Earth 
based models which are used to study these changes showed that cephalad fluid shifts distend 
baroreceptors of the central vasculature. This triggers the suppression of the renin-angiotensin-
aldosterone system (RAAS). Suppression of the RAAS leads to increased renal excretion of salt 
and water, and a net reduction in plasma volume (Vernikos 1995). Changes in the vestibular 
system, especially in processing inputs from otolith receptors, is another hypothesis to describe 
orthostatic intolerance. Altered gravity produces significant changes in the vestibular system and 
this leads to changes in sympathetic nervous system activity including blood pressure regulation 
(Yates and Kerman 1998). Further investigation is required to explain the relation between 
vestibular changes and orthostatic intolerance. 
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Musculoskeletal Changes in Microgravity 
The effect of actual and simulated microgravity on the musculoskeletal system is well 
documented. Absence of gravitational loading during spaceflight leads to muscle atrophy and 
bone demineralization. Weightlessness was shown to lead to changes in muscle structure and 
function. These changes appear mainly as a decline in muscle mass, volume, and strength (di 
Prampero and Narici 2003). Muscle atrophy mainly occurs due to imbalance in protein synthesis 
and degradation. In general, there is an increase in protein degradation and a decrease in protein 
synthesis, and loss of neuromuscular control. These causes are attributed to loss of gravitational 
loading. The most affected muscles are postural muscles, such as those found in the calf and 
thigh, that maintain our bodies in an upright position in a gravitational environment (Clément 
2011).  
Bone demineralization is a well-known health consequence of long duration spaceflight 
which was recognized even long before the first manned space mission. The loss of bone mass 
during spaceflight could eventually weaken the bone and increase the risk of fracture and so 
presents problems to astronauts upon return to a normal gravity environment. Studies of 
astronauts who spent months on space station Mir and Skylab, and also ground based models 
simulating microgravity, all showed that astronauts could lose 1-2% of bone mass. This loss 
occurred predominantly in load bearing areas of legs and lumbar spine (Vico et al. 2000; Lang et 
al. 2004; LeBlanc et al. 2007). Data from space ﬂight studies showed increased urinary and fecal 
excretion of calcium and increased markers of bone resorption. Calcium concentration is 
controlled mainly by parathyroid hormone (PTH) and calcitonin. PTH is responsible for bone 
resorption and thus activated when the blood calcium concentration is low. Normally, serum 
calcium and PTH are negatively correlated: when the level of calcium in the blood is low, the 
concentration of PTH will be high in response. Reduced levels of parathyroid hormone and 
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vitamin D in astronauts are expected physiologic responses to increased blood calcium resulting 
from microgravity-induced bone loss (Smith and Heer 2002). One possible explanation for this 
bone loss is the reduced gene expression of systemic hormones and growth factors (such as 
collagen Iα1, alkaline phosphatase, and osteocalcin) that are considered important for osteoblast 
differentiation (Carmeliet et al. 1998). Other studies showed a several fold increase in genes 
involved in osteoclast activity and maturation (Tamma et al. 2009). Impaired osteoblast function 
and increased osteoclast activity could explain osteoporosis like symptoms associated with space 
flight. 
The Effect of Microgravity on Immune System 
There is strong evidence associated with impaired immune system functions and space 
flight. Immune dysregulation in astronauts was first observed in the 1960s and 1970s as 
increased incidences of bacterial and viral infections were reported during or immediately after 
space flight. Fifteen of 29 Apollo crew members developed bacterial or viral infections during 
their missions or within the first week after their return (Hawkins and Zieglschmid 1975). Much 
is known about the immune health of astronauts from post flight testing of crew members, but 
little data are available about immunity during space flight. More in-flight investigation using 
human subjects is needed. These alterations of immune function could be attributed to high 
levels of physiological and physical stress during and immediately after space flight. Factors like 
radiation, microgravity, and altered sleep cycle could all affect the astronaut’s immune system. 
The few in flight studies that have been conducted have shown reactivation and increased 
frequencies of Epstein bar virus, varicella zoster virus and cytomegalovirus (Mehta et al. 2000, 
2003; Pierson et al. 2005). Reduced cell mediated immunity is also reported in in-flight studies 
(Gmünder et al. 1994). Post flight studies have revealed depression of T cell function during long 
duration flight, altered cytokine production, reduced function of natural killer cells and 
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granulocytes, and latent viral reactivation (Crucian et al. 2009). Altered cytokine production and 
potential shifts to a T-helper 2 (Th2) pattern lead to immune imbalance and adverse health 
conditions. For example, depressed immune response can result in increased incidence of 
infection, but heightened immunity may lead to allergies and autoimmunity. Microgravity could 
be associated with some impairments of immunity. In flight and ground-based models have 
shown that weightlessness impairs signal pathways essential for early T cell activation 
(Boonyaratanakornkit et al. 2005). Potential negative health consequences of prolonged immune 
dysregulation include hypersensitivity, autoimmunity, infectious diseases and even malignancies. 
So, it is important to determine the clinical risk of impaired immunity before initiating long 
missions to space.   
Genitourinary Problems During Spaceflight 
The genitourinary (GU) system is not uncommonly affected during space flight. Almost 
50 astronauts out of 508 crew members between 1981 and 1998 reported GU symptoms during 
space flights (Jones et al. 2005). GU symptoms can be categorized as: upper tract, lower tract 
and reproductive health. GU issues of upper tract during space flight are calculi and related 
obstruction. Data collected during short term space flight, long duration Mir missions and 
immediately after space flight have revealed increased urinary calcium and a decrease in both 
urinary volume and urinary pH resulting in a great risk of kidney stone formation (Whitson et al. 
1999). As mentioned earlier, bone loss associated with space microgravity lead to increased 
excretion of calcium by the kidneys and increased the urinary supersaturation of stone forming 
salts. Several cases of urinary tract infection and retention have also been reported during space 
flight. Multiple causative factors could be attributed to urinary tract infection. Stresses, 
dehydration, hygiene, and delayed access to voiding could play a role (Whitson et al. 1999). 
12  
  
Effective countermeasures should be taken since these issues don’t affect astronaut’s health only, 
but also affect the success of missions. 
With increased durations of space flight missions, an understanding of sex/ gender effects 
on reproductive health is needed. Major factors in the space environment that could affect 
reproductive health are: radiation, microgravity, and stresses. A 120-day Russian bed rest study 
found reduce numbers of active spermatozoa collected after 50-60 and 100 days of the study, and 
also an increase in the percentage of morphologically altered spermatozoa (Nichiporuk et al. 
1998). One ground-based study of male rats exposed to long duration simulated microgravity by 
hindlimb unloading (HU) for 6 weeks reported a significant decline in testicular weights and 
spermatogenesis, no spermatogenic cells were present and epididymides were devoid of mature 
sperm (Tash et al. 2002).  Another HU study documented adverse effects on the tissue that 
comprise the walls of the seminiferous tubules and the blood-testis barrier, with these changes 
noticeable after only 7 days of HU (Forsman 2012). 
With increased involvement of female astronauts in the space program including long 
duration space missions, more investigation is required to address the effects of the spaceflight 
environment on the female reproductive system. Because female astronauts use hormone 
supplements to suppress their menstrual cycles during spaceflight, reproductive changes in 
female astronauts have not been studied during or after space flight. The effects of spaceflight 
microgravity on menstrual functioning and microgravity induced retrograde menstruation need to 
be studied.  
Animal studies have provided data on some of the female reproductive changes 
associated with exposure to microgravity. Female rats exposed to simulated microgravity using 
the HU model have shown lengthening of diestrus phase of the reproductive cycle and therefore 
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lengthening of the estrous cycle (Tou et al. 2004). A prolonged diestrus cycle could result in 
reduction in the cumulative number of cycles and thus compromise fertility. Another study used 
2g centrifugation to study the effects of hypergravity on the female reproductive system of rats. 
This study found delayed conception in centrifuged rats compared to non-centrifuged rats. This 
study also showed that both centrifuged and non-centrifuged rats conceived, but centrifuged 
females took 3 times longer than non-centrifuged females to achieve conception (Ronca et al. 
2005). 
A study by Kojima et al. (2000) looked for the effect of simulated microgravity on 
mammalian fertilization and embryonic development in vitro using clinorotation. In vitro 
fertilization of 80 oocytes and 1x 10^6 sperm/ml were cultured in a microtube under clinostat 
rotation and stationary control conditions. Their results indicated that fertilization can occur in a 
simulated microgravity condition. But there was a significant decrease in the number of embryos 
reaching the morula and blastula stages after 96 hours of embryos culture under clinostat 
rotation. Another study investigated the effect of spaceflight on the event of parturition in female 
rats. These female rats were in mid pregnancy when flown on either 9 or 11 day long 
spaceflights. Each shuttle landed just 2-3 days before parturition. They found that flight female 
rats had uncomplicated successful vaginal delivery and delivery occurred at the appropriate 
gestational time, however the flight rats had twice the number of lordosis contractions compared 
with control group (Ronca and Alberts 2000).   
More recent studies have addressed the effect of microgravity on the mammalian female 
reproductive system. Mice that were flown for 13 days on the space shuttle Endeavor had a trend 
toward thinning of the mucin layer in the uterine tube compared with control group (Svalina and 
Forsman 2013).  Uterine tissues of female mice flown on the NASA shuttle mission STS-118 
had significantly thicker apical mucin layer than control groups (Forsman and Near 2013). The 
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thicker mucin layer in flight animals could be attributed to the effect of spaceflight on the 
pituitary- gonadal axis which could interfere with LH and FSH production. However, Smith and 
Forsman (2012) conducted a study to evaluate the morphological features of the ovaries of these 
same animals and found no gross morphological differences in follicle counts and number of 
corpora lutea between flight and control animals. Another study found that female mice who 
were exposed to 13 days of spaceflight had a thicker layer of mucin lining the vaginal canal than 
control mice (Romer and Forsman 2015). According to this study, spaceflight could have 
negative effects on sperm survival and may compromise the animal’s ability to reproduce. 
Although changes in mucin thickness were documented in these studies, it was unclear whether 
or not these changes were due to the microgravity of spaceflight, the radiation of spaceflight, or a 
combination of the two. 
Ground Based Models to Simulate Microgravity 
There are different earth-based techniques used to simulate microgravity and predict 
some effects of spaceflight on different body organs and systems. One example of these 
techniques is clinorotation via a device known as a clinostat. This device uses rotation to 
constantly change the gravitation vector so that the vectors cancel each other rendering no 
gravitational vector (Klaus 2001). Other examples are head-down bed rest and water immersion 
of humans. The last two techniques mimic the microgravity component of spaceflight because 
they induce cephalad fluid shifts and loss of loading on the musculoskeletal system (Epstein 
2011; Fortney et al. 2011). The HU model of rodents is the newest technique to simulate 
microgravity and weightlessness and it’s the technique used in our experiment so I will explain 
this technique in the following paragraph. These earth-based models are very beneficial in space 
exploration for several reasons: they are cost effective techniques, provide critical data without 
consuming valuable crew time, manipulations can be made with little to no cost increase, and 
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allow for variable experimental duration with multiple time points being measured throughout 
the experiment. Moreover, unlike spaceflight studies, the experiment can be repeated or extended 
as needed and tissues taken from the animal at any time during the experiment. 
The HU model has been accepted by the scientific community as the rodent model of 
choice to study the adverse effects of spaceflight microgravity and weightlessness on various 
body systems, especially the musculoskeletal system. The standard operating procedure for this 
technique was updated and approved by the National Aeronautics and Space Administration 
(NASA), Ames Research Center (ARC), and Flight Institutional Animal Care and Use 
Committee (Flight IACUC) on August 8, 2001. The development of HU model began in 1975 
with the results from un-manned spaceflight experiments compared with a HU model. COSMOS 
2044, was the first international spaceflight mission that include the HU model in the experiment 
as control group (Grindeland et al. 1992; Booth and Grindel 1994).  Both spaceflight and the HU 
model showed similar but not identical physiological responses in most of the body organs (Vico 
et al. 1991; Chapes et al. 1993; Tischler et al. 1993). The physiological responses that the HU 
model has to mimic include 1) differential muscle atrophy, 2) cephalad ﬂuid shift, 3) freedom to 
move and eat using the forelimbs, and 4) unloading of the hindlimbs without paralysis so that 
animals can recover from unloading (Morey-Holton and Globus 2002). There are many 
differences between HU simulated microgravity and actual spaceflight microgravity, therefore 
care should be taken when comparing results between spaceﬂight and HU experiments. The 
entire body is unloaded during spaceflight, while the forelimbs are weight bearing in the HU 
model. Therefore, responses in the HU model reflect partial effects of unloading of the 
musculoskeletal system on mammalian fertilization and embryonic development. Finally, the HU 
group does not experience launch, landing, or transportation to and from the launch and landing 
pad. 
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The HU technique as provided by NASA ARC is as follows. HU depends on using tail 
traction, surgical pins, or a back harness to unload the hindquarters of rats or mice. This causes 
cephalad fluid shifts and removal of gravity forces from hindlimbs, similar to what is seen in 
astronauts. Tail traction is used more in the HU model since it is associated with less stress and 
there is no need for anesthesia. Handling of the animals begins 1 week before the procedure. The 
animals are acclimated to the cages at least 2 days before unloading. It is recommended to avoid 
anesthesia, since recovery from anesthesia may affect the animal’s ability to adapt to HU. If 
anesthesia is used, then a 24-hour recovery period is needed before the procedure. The procedure 
begins with using alcohol to clean the tail and remove dirty or dead skin. The tail is allowed to 
dry, then sprayed with strong adhesive and allowed to dry for 1-5 minutes. When the spray is 
tacky, a piece of traction tape that was attached to the plastic tab, is attached to the tail, just 
above the hair line. The traction tape is then gently pressed to stick to the surface of the tail. Two 
strips of filament tape are used to secure the traction tape. One of the ﬁlament tape strips is 
secured around the edge of the traction tape at base of the tail, the second strip is placed about 
half-way up the traction tape. The filament tape should be loose enough to allow for adequate 
blood circulation, while still preventing the traction tape from peeling away from the tail. Gauze 
bandage can be wrapped around the base of the tail to protect the traction tape and to prevent the 
animal from peeling off the tape. A paper clip is then used to attach the animal to a ﬁsh-line 
swivel that hangs from the unloading device on top of the HU cage. The swivel is designed to 
prevent only the back feet from touching the cage’s floor while allowing the animal to move 
freely using the forelimbs. The animal’s body makes about a 30° angle with the floor of the cage. 
A 30° angle of unloading between the cage floor and the torso of the animal is the optimum 
degree to simulate spaceflight microgravity as it provides normal weight bearing on the 
forelimbs and induces cephalad fluid shifts.  As the angle increases, mechanical loading of the 
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forelimbs declines and traction on the tail increases. If the angle is too steep, the animals appear 
stressed. The cage sides can be adjusted to control the height of the unloading device and allow 
the animal to reach food and water. The animal’s overall appearance, activity, and the tail should 
be inspected daily to assure the health of the animals 
The Nature of Space Radiation 
  Space radiation consists mainly of three types of radiation: particles trapped in Earth’s 
magnetic field, energy from solar particle events, and galactic cosmic rays (GCRs) (NASA Facts. 
National Aeronautics and Space Administration, 2002). GCRs are the primary type of space 
radiation that astronauts are exposed to on the international space station (ISS), and also on 
future space missions. GCRs are considered ionizing radiation. Opposite to non-ionizing 
radiation, ionizing radiation has enough energy to knock the electrons out of any atoms it strikes 
causing biological changes of exposed cells and tissues. Astronauts are exposed to approximately 
50-2000 milliseivert (msv) in 6 months depending if they are on the ISS or the surface of moon 
or Mars (Barcellos-Hoff et al. 2015). Since radiation effect studies are difficult to carry out on 
human cells and tissues, the risks associated with radiation exposure should be obtained from 
ground-based studies using animal models. Ground based studies of radiobiological effects are 
largely limited to studies involving survivors of nuclear bombing events in Japan during world 
war II, cancer survivors who were exposed to radiation as part of their cancer treatment, and 
most recently people exposed to nuclear radiation resulting from nuclear disasters like ones in 
the Chernobyl nuclear power plant in Ukraine and the Fukoshima nuclear disaster in Japan. 
(Thompson et al. 1994; Cardis et al. 2006; Dörr and Meineke 2011). 
Sources and Effects of Radiation Exposure 
Radiation is all around us. The sources for ionizing radiation could be natural or man- 
made. Natural sources of radiation include: cosmic radiation and terrestrial radiation. Terrestrial 
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radiation is present in Earth’s crust in natural deposits of uranium and potassium. Natural sources 
could also be through inhalation of radioactive gases, such as radon, from the earth soil and 
minerals or through ingestion of trace amounts of radiation from some food contents or ground 
water (Washington State Department of Health 2002). Some man-made sources of radiation are 
used for medical purposes. The best-known application of radiation in the medical field are X-
ray machines for medical imaging and diagnosis and nuclear medicine which uses radioactive 
isotopes to treat cancer (Canadian Nuclear Safety Commission 2012). 
Radiation has been shown to have harmful effects on human health. The effect of 
ionizing radiation on human health depends on the total dose, exposure rate, and type of tissues 
exposed to radiation. The highest effect will be when exposure occurs in large doses over a short 
period of time. Some cells are more radiosensitive than others. Cells that are immature, 
undifferentiated, and have higher mitotic activity are more radiosensitive than mature, non-
dividing cells (Goodman 2010). Examples of radiosensitive tissues are blood cells, gonads, lens 
of the eye, and skin.  
The effect of ionizing radiation on the cellular level can be divided into direct and 
indirect damage. DNA is the major target in radiation damage. Ionizing radiation produces a 
wide range of DNA lesions, such as base damage, SSBs, double strand breaks (DSBs), and 
DNA-DNA and DNA-protein crosslinks (Prise et al. 2005). Base damage and SSBs’ repair occur 
via base excision repair and DNA ligation respectively. DSBs have been thought to be the most 
relevant lesion for cell killing. Homologous recombination (HR) and non-homologous end 
joining (NHEJ) are common repair pathways for DSBs (Jackson 2002). NHEJ is a dominant 
pathway in mammalian cells and it is more error prone than HR. Incorrectly repaired or 
unrepaired lesions can lead to DNA mutations or cell death. Cell death can occur through 
activation of programmed cell death pathways (such as apoptosis and autotrophy) or necrosis 
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(Brown and Rzucidlo 2011). Radiation induced apoptosis occurs through intrinsic pathways 
which involve changes in mitochondria or through activation of caspase enzymes that 
specifically cleave proteins (Prise et al. 2005). 
Absorption of ionizing radiation by cells can generate reactive chemical species (reactive 
oxygen species, reactive nitrogen species) that may cause damage to DNA, proteins, and lipids. 
This effect of radiation is called indirect effect of radiation and it contributes to more damage 
than the direct effect. Because 80% of cellular content is water, ionizing radiation can cause 
hydrolysis of water to produce hydrogen molecules and hydroxyl free radical (.OH). Hydroxyl 
free radical has an unbound electron and therefore higher affinity to react with other molecules. 
When two hydroxyl molecules bind to each other, they form hydrogen peroxide which is highly 
toxic (Brown and Rzucidlo 2011).   
There are two types of radiation induced injury, stochastic and deterministic (Brown and 
Rzucidlo 2011). Deterministic injury occurs once the threshold of radiation exposure has been 
exceeded. The severity of deterministic injury increases as the dose increases. Examples of 
deterministic effects include skin erythema, cataracts, epilation, and sterility. Acute radiation 
syndrome is a form of deterministic injury that occurs when exposed to large doses of radiation 
in a short period of time. Signs and symptoms of acute radiation syndrome begin with 
gastrointestinal symptoms, nausea, vomiting, diarrhea, and fluid loss. Neurological damage may 
occur in larger doses (Dörr and Meineke 2011).  
Stochastic effects or long-term effects of radiation are those effects that could appear 
years after radiation exposure. These late effects of radiation may result from previous high dose 
exposure or from chronic low dose exposure over years. Long term effects could appear as 
increased incidence of cancer or hereditary defects. The first reported increase in cancer risk 
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associated with radiation exposure was a report in 1944 of a 10-fold increase in leukemia among 
radiologists (March 1994). Most of the data about radiation induced cancer comes from 
epidemiological studies in human populations receiving radiation exposure from occupational, 
medical, and accidental sources. An epidemiological study done 20 years after the Chernobyl 
accident showed a dramatic increase in incidence of thyroid cancer (Cardis et al. 2006). Another 
epidemiological study on Hiroshima and Nagasaki atomic bomb survivors showed significant 
increases in solid tumors in most tissues (Thompson et al. 1994).  
RIBE stands for radiation induced bi-standard effect, and is another effect of radiation. 
RIBE challenged the conventional dogma that radiation affects only the exposed cells and does 
not have any effects on non-exposed cells. RIBE can be defined as the phenomenon in which 
irradiated cells can release signaling molecules, which transfer via gap junctions to non-
irradiated cells and cause similar toxicity or genetic damage (Han and Yu 2010). By looking at 
the radiation effects from epidemiological studies and cancer survivors, we can predict similar or 
more sever effects from galactic cosmic radiation on various body organs depending on the 
duration the astronauts spend on the international space station, or the surface of the moon or 
Mars. 
Effect of Radiation on Reproductive Health 
Ionizing radiation has effects on gonads. The degree of damage depends on many factors 
such as the dose, duration and age of exposure (Goodman 2010). The testis is one of the most 
radiosensitive tissues. Radiation exposure to testis occurs through therapeutic, diagnostic, and 
occupational exposure. Many studies have investigated the effect of radiation on gonadal 
functions.  These studies were conducted on cancer survivor patients who were exposed to pelvic 
radiation and to people who were exposed to radiation from atomic bombs. Long term studies 
investigating the effect of ionizing radiation on testis have shown that reversible azoospermia 
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and decreased levels of testosterone may occur after dose of 0.35 Gy, indicating that radiation 
affected Leydig cell function (Rowley et al. 1974). However, a radiation dose above 2 Gy could 
cause permanent aspermia (Ogilvy-Stuart and Shalet 1993).  
Many studies have also documented the negative effects of radiation on the female 
reproductive system. The female reproductive system is highly susceptible to late effects of 
radiation exposure. Potential late effects on the female reproductive system can occur as a result 
of radiation exposure to the hypothalamic pituitary- ovarian axis (HPO), ovaries, and uterus 
(Bath et al. 2002). One of the most common late effects of radiation is ovarian failure as a result 
of depletion of the finite number of follicles. One study investigating the effect of total body 
irradiation (14 Gy) in childhood and adolescence on ovarian and uterine characteristics has 
shown ovarian failure, reduced uterine volume and reduced blood supply to the uterus (Bath et 
al. 1999). An ovarian dose of 4 Gy may cause a 30% incidence of sterility in young women, but 
100% sterility in women over 40 years of age (Ogilvy-Stuart and Shalet, 1993). 14-30 Gy of 
radiation to the uterus is associated with reduced uterine volume, reduced myometrial elasticity, 
and some uterine vascular damage (Gnaneswaran et al. 2012). Radiation exposure to the uterus 
has also been linked to pregnancy complications such as the increased possibility for 
miscarriage, premature delivery, still birth, and low weight birth (Gnaneswaran et al. 2012). 
Endometrial Cancer 
Endometrial carcinoma, commonly referred to as uterine cancer, is the most common 
type of female genital tract cancer in the United States, with approximately 43,470 new cases 
diagnosed in the U.S in 2010, and about 7,950 deaths from the disease each year (Naumann 
2011). The endometrium consists of an epithelial glandular component and a stromal component. 
The endometrium lines the uterine cavity and undergoes changes in response to estrogen and 
progesterone. Both stroma and glands proliferate under the influence of estrogen in the first half 
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of the menstrual cycle. In the second half of the cycle, the endometrium differentiates in 
preparation for implantation of an embryo under the influence of progesterone. If implantation 
does not occur the endometrium sloughs off and the cycle begins again. The endometrium 
undergoes well controlled proliferation and differentiation in premenopausal women. 
Endometrial carcinoma may arise when hormonal imbalance or genetic alterations affect this 
cycle (Di Cristofano and Ellenson 2007).  
There are two different pathological types of endometrial carcinoma, type 1 and type 2. 
Type 1 arises in women with metabolic and hormonal disturbances such as, obesity, 
hyperlipidemia, diabetes, and hyper estrogenic state (Sherman et al. 1997). Type 1 carcinoma is, 
also called endometrioid carcinoma.  It is moderate to well differentiated (low grade), confined 
to uterus (low stage), has favorable prognosis (85% 5-year survival rate), and is often associated 
with hyperplasia (Bokhman 1983). Type 2, also called serous carcinoma. It arises in women 
where endocrine and metabolic disturbances are absent or unclear. Type 2 are considered poorly 
differentiated tumors, with a deep tendency to myometrial invasion. They are estrogen 
independent, have doubtful prognosis (58% 5-year survival rate), and appear as atrophic lesions 
(Sherman et al. 1997; Bokhman 1983). Type 1 carcinoma is the most common type of the 
endometrial carcinoma, representing approximately 85% of cases, while serous carcinoma 
represents approximately 10% of cases (Di Cristofano and Ellenson, 2007).  
Genetic Alterations Involved in the Development of Uterine Cancer 
It has been shown that genetic alterations involved in the development of type 1 cancer 
differ from type 2 cancer and each one has a different gene expression profile. Type 1 shows 
mutations in the phosphatase and tensin homologue deleted on chromosome 10 (PTEN), 
PIK3CA, K-RAS and β-catenin genes. It is also associated with microsatellite instability (MI). 
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While type II have loss of heterozygosity (LOH) on several chromosomes and alterations of p53 
(Yeramian et al. 2012). 
The tumor suppressor gene, PTEN, has been shown to be mutated in a wide variety of 
human tumors like brain, breast and prostate cancer and is the most frequently altered gene in 
endometrioid carcinoma (Li 1997). PTEN is located on chromosome 10q23. This region of the 
genome undergoes loss of heterozygosity in approximately 20-30% of endometrioid endometrial 
carcinoma (Di Cristofano and Ellenson 2007). PTEN mutation is also detected in almost of 37-
61% of endometrioid endometrial carcinoma cases (Yeramian et al. 2012). In contrast to other 
tumor types with PTEN mutation, PTEN mutation is observed in endometrial hyperplasia and 
thus its mutation occurs early in the pathogenesis of endometrial cancer (Levine et al.  1998). 
The PI3K/AKT Pathway  
PTEN is the most frequently mutated gene in endometrial cancer and leads to activation 
of the PI3K/ AKT pathway and thus malignant transformation (Banno et al. 2012). The PI3K 
pathway is the most commonly altered pathway in the pathogenesis of endometrial cancer 
(Tashiro et al. 1997). The PI3K pathway transmits growth factor signals from transmembrane 
kinase receptors to activate cellular proliferation and survival mechanism. PI3K enzymes are 
categorized into three major classes: IA PI3K, IB PI3K, and class II PI3K. Class IA PI3Ks have 
been associated with malignant transformation in many cancer types. Class IA PI3Ks exist as 
heterodimers made up of a p110 catalytic and p85 regulatory subunit (Naumann 2011). Once the 
ligand binds to a tyrosine kinase receptor, a conformational change occurs in p-85 to release its 
inhibition of a p-110 catalytic site. Active p-110 converts phosphatidyl inositol 4,5 bi-phosphate 
to phosphatidyl inositol 3,4,5-triphosphate(PIP3). This leads to recruitment and activation of 
AKT proteins. PTEN acts as a negative regulator of the PI3K pathway by converting PIP3 back 
to PIP2, thus preventing AKT recruitment and activation. Therefore, mutation of PTEN leads to 
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over activation of PI3K pathway (Osaki et al. 2004). AKT, serine threonine kinase, is one of the 
important downstream components of the PI3K pathway. Activated AKT promotes cellular 
growth, proliferation, angiogenesis, and prevents apoptosis (Yamaguchi and Wang 2001). There 
are three isoforms of AKT proteins, AKT1, AKT2, and AKT3 and they share the same common 
structure among different species (Fayard 2005). The AKT proteins consist of three domains; an 
N-terminal domain that binds with different proteins on the plasma membrane, a central kinase 
domain and a C-terminal regulatory domain (Fayard 2005). Conversion of PIP2 into PIP3 leads 
to translocation and recruiting of AKT from the cytoplasm into the plasma membrane to bind 
with PIP3 via its N-terminal domain. The activation of AKT is a multistep process that requires 
phosphorylation of threonine 308 in the central kinase domain and phosphorylation of serine 473 
within the C-terminal regulatory domain. Phospho-inositol dependent kinase (PDK1) is the 
enzyme responsible for phosphorylation of threonine 308, while mTORC2 (the mammalian 
target of rapamycin complex) is the last candidate kinase that is assumed to be responsible for 
phosphorylation of Serine 473 (Naumann 2011). Once activated, AKT acts as the central node of 
the PI3K pathway and controls multiple downstream effectors that lead to cellular growth and 
proliferation (figure 1). 
In this study we conducted immunohistochemical staining employing a pan AKT 
antibody which detects all three isoforms of AKT (AKT1, AKT2, AKT3) either in 
phosphorylated or non-phosphorylated states. We also used a phospho-AKT antibody in our 
Western blot analysis. The phosphor-AKT antibody that we used in western blot detects 
phosphorylation sites at serine 473, which is located in the C-terminal regulatory domain of all 
AKT proteins. We choose to study this pathway for 2 reasons, first: as mentioned earlier most of 
the pathogenesis of endometrial carcinoma involves mutation in the PTEN gene and thus over-
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activation of PI3K, second: radiation and stress seems to activate multiple intracellular signaling 
pathways including PI3K pathway and MAPK pathway (Dent et al. 2003). 
The MAPK Pathway 
The mitogen-activated protein kinase (MAPK) cascade is an intracellular signaling 
pathway that regulates different cellular activities including cell growth, cell cycle regulation, 
cell survival, angiogenesis, and cell migration. Like the PI3K pathway, the MAPK pathway can 
be activated when a ligand binds with a tyrosine kinase receptor on the cell surface or other 
receptors like G-protein coupled receptor and cytokine receptors (Friday and Adjei 2008). 
The MAPK pathway includes several signaling molecules such as RAS, RAF, MEK, and 
ERK. The activation of this pathway begins when a mitogen binds and activates cell membrane 
receptor tyrosine kinase causing a downstream signaling cascade. Activated tyrosine kinase leads 
to activation of GTPase RAS protein that resides in the plasma membrane and acts as an 
upstream switch for activation of other downstream effectors in the MAPK pathway. Activated 
RAS leads to recruitment and activation of serine threonine RAF kinases. Active RAF proteins 
in turn phosphorylate and activate MEK1 and MEK2. MEK1 and MEK2 are serine/threonine and 
tyrosine kinases that activate and phosphorylate extracellular signal regulated kinase (ERK1) and 
ERK2. ERK proteins have numerous downstream effectors which regulate cell growth and 
proliferation (McCain 2013). Oncogenic alterations in the RAS/MAPK pathway are found in 
endometrial cancer in the form of activating KRAS mutations (Duggan et al. 1994). The 
mutation of KRAS has been found in 10-30% of endometrial carcinomas (Dobrzycka et al. 
2009). 
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Figure 1: Overview of The PI3K/AKT and MAPK pathways (Carnero and Paramio 2014).   
 
Objectives and Significance of this Study 
There were two major aims of this study:  
Specific aim 1: To determine the effect of high radiation exposure and simulated spaceflight 
conditions on the incidence of uterine cancer. 
Specific aim 2: If cancer is detected, to identify the cell type affected. 
Uterine cancer is the fourth most common cancer in women in the United States and the 
most commonly diagnosed gynecologic cancer. In 2013, 50,560 women in the United States 
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were diagnosed with uterine cancer. 9,325 women in the United States died from uterine cancer 
in that year (U.S. Cancer Statistics Working Group 2017). In the United States roughly 1 in 530 
people between the ages of 20-39 is a childhood cancer survivor (CureSearch for Children's 
Cancer 2018). The unique health related issues faced by these cancer survivors has not been 
adequately studied. Irradiation used in the treatment of childhood cancers has been shown to 
have long term effects on female reproductive structures, especially the ovary and the uterus. 
Exposure to radiation therapy in childhood has impaired uterine function, causing reduced 
uterine volume, decreased myometrial elasticity, and some uterine vascular damage 
(Gnaneswaran et al. 2012). However, the effect of radiation directly on the reproductive tissue 
has not been examined. Disruption to normal reproductive functions are of great public health 
concern as they increase the health issues in the mother and cause higher rates of mortality in the 
offspring. The space flight environment is also high in radiation. As humans continue venturing 
deeper and longer into space, they will be exposed to a high radiation environment.  This is 
expected to cause effects similar to those seen in clinical irradiation. Our study addressed the 
changes associated with radiation and microgravity in female reproductive tissues, especially the 
increased risk for uterine cancer. 
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CHAPTER 2 
MATERIALS AND METHODS 
All tissues utilized in this study came from the laboratories of Drs. Xiao Mao and Mike 
Pecaut of Loma Linda University in Loma-Linda, California. Six month old C57 BL/6 female 
mice were maintained 4/cage under a constant ambient temperature of 65.8°F with a 12h 
light/dark cycle. After 1 week of acclimatization, the animals were randomized into 4 groups 
(6/group) as follows: 1) age-matched controls, 2) low-dose-rate (LDR) γ-irradiation, 3) 
unloading with tail suspension, and 4) LDR + tail suspension. Cobalt57 (57CO) plates (0.04Gy at 
0.01cGy/h) were used to deliver irradiation to the whole body of 6-month-old adult C57 BL/6 
mice (n=4-6/group) to simulate the radiation of spaceflight. Anti-orthostatic tail suspension, also 
known as HU, was used to model the unloading, fluid shift, and physiological stress aspects of 
spaceflight. Mice were hindlimb suspended and/or irradiated for 21 days to test the potential 
interaction. In that 21-day unloading period, the mice were individually housed. Mice were 
euthanized with 100% CO2. Mice were euthanized either 1 month, 4 months, or 9 months 
following completion of treatment (radiation, HU, or radiation combined with HU). Vaginal 
smears were performed on each animal at the time of euthanasia to allow estrous cycle stage 
determination. Uterine tissues were harvested by a laboratory technician within 30-60 minutes of 
euthanasia. Following excision, the uteri were separated into left and right portions. One portion 
was placed in RNAlater and the other portion was preserved in 4% paraformaldehyde. The 
tissues were then sent to the laboratory of Dr. Allan Forsman at East Tennessee State University. 
Upon arriving, paraformaldehyde preserved tissues were trimmed of fat and stored in 70% 
ethanol (ETOH). Tissues stored in RNAlater were placed in -80° C storage for later analysis.   
Uterine tissues stored in RNAlater were divided into two sections. One section was used 
in Western blot analysis while the other section was returned to the RNAlater for future analysis.  
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Western Blot Procedure 
Uterine tissues were homogenized in 280 µl of RIPA buffer (150 mM NACL, .1% triton 
x-100, 0.5% sodium deoxycholate, 0.1% SDS and 50 Mm TrisHCL [ PH 8.0]) with 100 µl 
protease inhibitor cocktail (category # B14001), 100 µl phosphatase inhibitor cocktail (category 
# B15001-B) and 100 µl phosphatase inhibitor cocktail (category # B15001-A). Homogenate 
was centrifuged for 10 min at 16,000 RPM (Revolutions Per Minute) and placed on ice. The 
supernatant was then aspirated and placed in a fresh microfuge tube kept on ice. Proteins were 
quantified using the Bradford assay. The Bradford protein assay depends on using standard 
proteins of known concentration to create standard curves and equations that will be used to 
estimate the concentration of protein of unknown solutions. This method is based on the 
proportional binding of Coomassie blue dye to proteins. When there are more protein contents in 
the solution, more Coomassie dye will bind with protein and create a significant change in color 
of the mixture. The Bradford assay uses Coomassie brilliant blue G250 which has a red brown 
color in acidic solution, but when proteins bind with this dye the color turns blue. The protein-
bound form of the dye has an absorption spectrum maximum at 595 nm. The increase of the 
absorbance at 595 nm is positively correlated with the amount of the bound dye and with the 
amount of protein in the solution. A spectrophotometer was used to measure the light intensity of 
light being absorbed or reflected and express these intensities in the form of absorbance values. 
For this assay we used the dye reagent and protein assay standards which are set at seven 
prediluted concentrations (1000, 500, 250, 125, 62.5, 31.25, 15.625 µg/µl).  The first step in 
protein quantification is dilution of protein samples with distilled water then vortex. This step 
was necessary because homogenization was done in RIPA buffer and RIPA buffer interferes 
with the protein-dye interaction. Because of this interference the protein samples should undergo 
a 40 – 50 X dilution before beginning the protein estimation. To accomplish this, 245 µl of 
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distilled water was added to 5 µl protein samples. Then 30 µl of diluted protein samples and 
standards were added to the wells of assay plate. For accuracy this last step was performed in 
triplicate. For each well containing the samples and the standards, 270 µl of Coomassie plus (pro 
# 1856209) was added and incubated for 10 minutes at room temperature. A spectrophotometer 
was used to read the plate and obtain the readings of standard protein concentration versus the 
absorbance. A standard curve calculated from the readings of the standards was used to predict 
the concentration for our protein samples. 
To prepare samples for western blotting, the sample tubes were placed in a hot plate at 
100℃ for 5 minutes, placed on ice for 5 minutes, then vortex and spun. An equal amount of 
protein was loaded into the wells of TGx pre-cast gels (category # 456-1086, lot # 64074007). 5 
µl of ladder was added to the first lane (category # 26616) and 15 µl of each sample was added 
to the remaining lanes. The container was filled with running buffer and the gel was run at 300 
volts for 25 minutes. Protein was transferred to an Immobilon polyvinylidene fluoride (PVDF) 
membrane over 1 hour using 100 V. After 1 hour the membrane was stained with ponceau red to 
check the transfer quality. The membranes were then washed with TBS-T 3x for 5 minutes, then 
blocked in 10 ml western blot blocking (TBS, 2% bovine serum albumin, 2% fetal calf serum, 
0.1% sodium azide) for 1 hour. Membranes were exposed to a 1:1000 primary antibodies (10 ml 
of TBST, 10 µl of phospho AKT, and 10 µl of 20% sodium azide) of rabbit anti- mouse phospho 
AKT (cat # 4051). Membranes were washed with TBS-T three times for five minutes. Then 
membranes were incubated with appropriate 1:10000secondary antibodies (2.5 µl of goat anti 
rabbit #31460, 0.5 g of non-fat milk, 25 ml of TBST) coupled to horse radish peroxidase (HRP) 
for 1 hour at room temperature.  After washing the membranes three times for 5 minutes, signals 
were visualized using chemiluminescent lumigen (100 µl of reagent A, 100 µl of reagent B and 1 
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ml of distilled water). Then we used alpha view software to read the band intensity of the target 
proteins. 
Membranes were stripped using mild stripping buffer for 10 minutes, PBS was added two 
times for 10 minutes and poured off, then TBS-T was added two times for 5 minutes and poured 
off. Membranes were blocked again with western blot blocking buffer. Membranes were then 
ready for application of other primary antibodies such as rabbit anti- total AKT (468S), rabbit 
phospho mapK 42/44 (Cat # 4370), total 42/44 ERK, and β-tubulin. β-tubulin was used as a 
housekeeping protein to do normalization with target proteins. Membranes were incubated for 1 
hour with appropriate secondary antibody (goat anti mouse #7076s or goat anti rabbit #31460).  
Histological Examination  
Paraformaldehyde preserved uterine horns were divided into proximal, middle, and distal 
portions. The middle portion was embedded in paraffin for use in this study. The first step in 
tissue processing is tissue dehydration. Because paraffin is immiscible in water, tissue 
dehydration is required to remove water from tissues before paraffin infiltration is performed.  
Paraffin embedding is necessary to render the tissue firm enough to be sectioned on a 
microtome. In order to infiltrate the tissue with paraffin the water/fluid component of the cell 
must be replace with melted paraffin. This is accomplished by immersing the tissue in increasing 
concentrations of ETOH until the tissue is infiltrated with 100% ETOH. To accomplish this 
infiltration the tissue is removed from the 70% ETOH in which it was stored and placed on 80% 
ETOH for 30 minutes. The tissue is then moved to 90%, ETOH, 95% ETOH, 95% ETOH, and 
finally 100% ETOH for 30 minutes each, with the 100% stage done twice. This gradual 
dehydration prevents distortion and damage of the cells/tissue. Because ETOH is not miscible 
with paraffin, further steps must be taken to replace the ETOH with melted paraffin. This is 
accomplished by immersing the tissue in a 50:50 mixture of 100% ETOH and a dehydrating 
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agent known as Citrisolv for 30 minutes. It should be noted that Citrisolv is miscible with both 
ETOH and paraffin. Following this 30-minutes immersion the tissue is place in 100% Citrisolv 
for 30 minutes followed by immersion in a 50:50 mixture of Citrisolv and melted paraffin. This 
stage, and all subsequent stages must be carried out at 60-65°C to insure the paraffin remains 
liquid. The tissue is then immersed in 100% paraffin for 1 hour followed by another 1-hour 
immersion in another container of 100% paraffin. Following the second hour of 100% paraffin 
immersion the paraffin is placed in an embedding mold that has been treated with mold release. 
Mold release is made of a solution consisting of 5 ml of glycerin and 400 ml of 75% ETOH. 
Embedding molds are treated by immersion in mold release and then allowing to dry and then 
repeating this step. The remaining steps in the embedding procedure are carried out on a tissue-
Tek embedding console. One the tissue is place in the embedding mold a small amount of melted 
paraffin is dispensed into the embedding mold and the tissue is centered in the embedding mold. 
Once the tissue is in the desired position the embedding mold is moved to the cooling plate of the 
console and an embedding ring is added to the top of the embedding mold. Melted paraffin is 
then added to the embedding ring until the ring is filled. The embedding mold/ring assembly is 
then moved to the final cooling area of the embedding console and the paraffin allowed to 
cool/solidify. Once solidified the tissue/block can be stored indefinitely.  
 Embedded tissues were then sectioned at 4µm and placed on glass microscope slides. 
Slides were then stained using a standard H&E staining technique. The slides were examined 
microscopically for visible signs of cancer. 
For immunohistochemical (IHC) staining we prepared three microscopic slides for each 
specimen. Two slides had the primary and secondary antibodies, while the third slide had 
negative control, or had primary or secondary antibody only. The primary antibody used in this 
procedure was a pan-AKT antibody (cat#8805).  IHC staining was used to identify the presence 
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and location of AKT in these tissues. The first step in IHC was deparaffinizing and rehydrating 
the tissue sections using xylene and series of alcohol concentrations. Paraffin should be removed 
to expose the epitope and allow its binding with primary antibody. Also, failure to remove 
paraffin will trap excess chromogen causing background staining.  Rehydration will be important 
to allow the target antigen to interact with antibodies. Deparaffinization is accomplished by 
immersing microscopic slides twice in xylene for 3 minutes each. Then slides are immersed in 
series of alcohol concentrations for rehydration. The slides immersed in 100% ETOH, 95% 
ETOH, 80% ETOH, and 70% ETOH for 3 minutes each with 100% stage done twice.  Finally, 
tissues were immersed in distilled water 3 times for 3 minutes each.   
Microscope slides were then placed in a container filled with tap water and transferred to an 
autoclave for 15 minutes at 122°C of wet cycle. This step was done to retrieve and unmask the 
antigen binding sites that were crosslinked during the paraformaldehyde fixation. Following 
antigen retrieval 3% hydrogen peroxide was applied to each slide to prevent endogenous 
peroxidase activity and therefore prevent nonspecific binding and false positive detection. This 
blocking step was performed at room temperature for 45 minutes. Slides were then rinsed with 1-
X rinse buffer (LOT# 2834466). To prepare 100 ml of 1X rinse buffer we added 5 ml of 20X 
rinse buffer from the IHC kit, 95 ml of distilled water, and added 100 µl of tween 20. To prevent 
nonspecific binding of primary and secondary antibodies with non- antigen proteins, we applied 
2 drops of blocking reagent to the specimen and incubated at room temperature for 45 minutes in 
an enclosed container. The slides were then rinsed with 1X rinse buffer.  Two types of blocking 
solution were used during the procedure, blocking reagent in IHC kit (LOT# 2834466) which 
was later replaced with carrier solution (1 ml of normal goat serum, 1.5 grams of bovine serum 
albumin, 1.5ml of 20% triton X-100, and 97.5 ml of PBS). Normal serum carries antibodies that 
will bind to the non-specific epitopes in the sample, thus preventing non-specific binding with 
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primary antibody. A serum identical to the host animal of the secondary antibody or from an 
unrelated species is recommended to prevent interactions with primary or secondary antibodies, 
or with the tissues/cells being stained. 
Two drops of blocking solution were added per slide and the slides subsequently 
incubated for 45 minutes at room temperature. The next step was rinsing and applying primary 
antibody 1: 1000 (1 µl of p-AKT cat # 8805, 998.5 µl of PBS, and 0.5 µl of tween 20). Primary 
antibody was applied at 4°C overnight. The slides were then rinsed with 1X rinse buffer. 
Secondary antibody was applied for 45 minutes at room temperature. The antigen bound 
antibody was then localized by adding streptavidin HRP (two drops for 45 minutes) which 
generates amplified signal when chromogen reagent is added. The IHC kit we used contained 
two bottles of chromogen reagent, DAB chromogen A and B. We mixed chromogen A and B in 
a 1:25 ratio and applied to the slides for ten minutes then rinsed. Hematoxylin counterstain was 
applied for 1 minute, rinsed, and placed in container filled with tap water. The counterstain 
provides contrast to primary stain and helps to pin point the exact position of positive staining 
cells. The last step in IHC was sealing the sample and prevent enzymatic produced solubilization 
by dehydration through a graded series of alcohol and xylene based mounting media (paramount) 
followed by cover slipping. Dehydration is accomplished by immersing slides in 70% ETOH, 
80% ETOH, 95% ETOH, 100% ETOH for two minutes each with the 100% ETOH stage done 
twice. Then slides are immersed twice in citrisolv for 3 minutes each and then cover slipped. 
To evaluate the IHC results, the slides were scored in triplicate (each slide was read three 
times by the same observer) using the combined location and intensity scoring system, where a 
score of 0 indicates no staining reaction or weak focal reaction, a score of 1 for intense focal or 
mild diffuse reaction, a score of 2 for moderate diffuse reaction, and a 3 for intense diffuse 
reaction (Fedchenko and Reifenrath 2014). 
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Statistical Analysis 
Relative band densities of western blots were calculated for each protein of interest using 
alpha view software. These were normalized to β-tubulin controls for graphical depiction of 
western blot results. Graph Pad Prism 7 was used for the statistical analysis and generation of 
graphs. Data were summarized by the mean and standard deviation. Group mean responses were 
compared by one-way analysis of variance (ANOVA) where p-values of 0.05 or smaller were 
considered significant. 
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CHAPTER 3 
RESULTS 
Gross Morphology of H&E Stained Uterine Tissues 
To investigate possible uterine morphological and structural changes induced by 
simulated microgravity, whole body radiation, or the two-combined, hematoxylin and eosin 
(H&E) staining of the uterine tissues was performed. The gross morphology of the H&E stained 
tissues was microscopically evaluated. Represented examples of these stained tissue can be seen 
in figure 2. Results of the H&E staining revealed no differences between these samples at the 
gross morphological level. No indication of abnormal sizes or shapes of cells or abnormal 
growth was noted.                                                         
Figure 2A                                            Figure 2B 
      
Figure 2C                                            Figure 2D 
    
Figure 2: Longitudinal section of H&E stained uterine tissues from the animals sacrificed 9-
months post treatment (X100) for A) control mouse, B) radiated mouse, C) unloaded mouse, and 
D) radiated and unloaded mouse. 
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Immunohistochemical Evaluation 
To investigate the possible cancer-causing effects of whole body radiation, HU, or a 
combination of the two on uterine tissues, we used immunohistochemical staining (IHC) using a 
pan AKT antibody. The IHC staining results show that uterine tissues from animals sacrificed 4 
months post treatment had mild diffuse expression of AKT. There was no difference between the 
control and other treatment groups as seen in figure 3.  
Figure 3A                                                    Figure 3B                      
            
Figure 3C                                                    Figure 3D 
            
Figure 3: Longitudinal section of IHC stained uterine tissues from the animals sacrificed 4-
months post treatment (X100) for A) control mouse, B) radiated mouse, C) unloaded mouse, and 
D) radiated and unloaded mouse.     
  
There is no difference in AKT expression level between the various treatment groups in 
the tissues from the animals sacrificed 9 months post treatment. However, the positive staining 
reaction was moderate to intense diffuse compared with the various treatment groups in the 
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tissues from the animals sacrificed 4 months post treatment as shown in figure 4. IHC staining 
results also show that AKT expression was visible in both the endometrial and myometrial layers 
of the uterus as shown in figure 4E. 
Figure 4A                                                    Figure 4B                                                                                   
            
Figure 4C                                                    Figure 4D 
            
Figure 4E                                                                 
 
Figure 4: Longitudinal section of IHC stained uterine tissues from the animals sacrificed 9-
months post treatment (X100) for A) control mouse, B) radiated mouse, C) unloaded mouse, D) 
radiated and unloaded mouse, E) and R/UN section show AKT positive staining in both 
endometrial and myometrial layers. 
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Western Blot Analysis 
Expression of pAKT in 4 Months and 9 Months Post Treatment Uterine Tissues 
To investigate whether or not whole-body radiation, HU, or the combination of the two 
causes over activation of the PI3K pathway, western blot analysis was performed to identify the 
level of pAKT proteins in 4 months and 9 months post treatment samples. There was no 
significant difference of pAKT protein level normalized data between control, HU, radiated, and 
radiated and unloaded groups in both 4 months and 9 months post treatment samples as seen in 
figures 5 and 6. 
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Figure 5: pAKT content in uterine samples from animals sacrificed 9 months post treatment. A: 
Representative Western blot of Uterine pAKT protein; B: Densitometry of the ratio of pAKT 
bands to total AKT. No statistical difference between groups (p = 0.82). Data was expressed as 
the mean ± SD (n = 3 mice/group). 
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Figure 6: pAKT content in uterine samples from the animals sacrificed 4 months post treatment. 
A: Representative western blot of Uterine pAKT protein level; B: Densitometry of pAKT bands 
normalized to β-tubulin. No statistical difference between groups (p = 0.11). Data are expressed 
as the mean ± SD (n = 2-3 mice/group). 
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Expression of pMAPK in 4 Months and 9 Months Post Treatment Uterine Tissues 
 
To investigate whether or not radiation, HU, or a combination of the two over activate the 
MAPK pathway, western blot analysis was performed to identify the level of phospho ERK and 
total ERK from the animals sacrificed 4 months and 9 months post treatment. Western blot 
analysis revealed no significant difference of phospho ERK normalized data among control, 
unloaded, radiated, and radiated and unloaded groups (p>0.05) as seen in figures 7 and 8. 
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Figure 7: pERK content in uterine samples from the animals sacrificed 9 months poste treatment 
A: Representative Western blot of Uterine pERK protein level; B: Densitometry of the ratio of 
pERK bands to total ERK. No statistical difference between groups (p =0.99). Data was 
expressed as the mean ± SD (n = 3 mice/group). 
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Figure 8: pERK content in uterine samples from the animals sacrificed 4 months poste 
treatment. A: Representative Western blot of Uterine pERK protein level; B: Densitometry of 
pERK bands normalized to β tubulin. No statistical difference between groups (p = 0.34). Data 
was expressed as the mean ± SD (n = 2-3 mice/group). 
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CHAPTER 4 
 
DISCUSSION AND CONCLUSIONS  
 This study was designed to investigate whether radiation, simulated microgravity or both 
may increase the incidence of uterine cancer, and if so, which portion/s of the uterus, 
endometrium or myometrium, are more vulnerable. Experimental studies using animal models 
and epidemiological studies of atom bomb survivors and survivors of nuclear accidents have 
shown radiation to be a universal carcinogen (Little 2000). The carcinogenic effect of radiation 
comes from radiation’s ability to penetrate protective cellular barriers and deposit energy inside 
cells. Radiation is known to cause cancer by one of three mechanisms: alteration in the structure 
of genes or chromosomes, alteration in gene expression, or through oncogene viruses (Beir 
1990). 
PI3K and MAPK pathways are common intracellular pathways that have been shown to 
be activated in uterine cancer (Yeramian et al. 2012). The PI3K pathway activation begins when 
a ligand binds to tyrosine receptor kinase causing PI3K enzyme to convert PIP2 into PIP3. This 
leads to recruitment of a cytosolic inactive form of AKT to the plasma membrane where it binds 
with PIP3. AKT binding with PIP3 induces conformational changes of AKT which enables its 
activation by various kinases in the plasma membrane. PDK1 enzyme phosphorylates AKT at 
threonine residue, while mTORC2 directly phosphorylates the serine residue of AKT. This 
double phosphorylation fully activates AKT. AKT is one of the major downstream effectors of 
the PI3K pathway. Activated AKT in turn activates other effectors important for cell growth and 
proliferation. The PTEN gene, which is highly mutated in uterine cancer, acts as negative 
regulator of the PI3K pathway by conversion PIP3 back into PIP2 which prevents AKT 
recruitment and activation. 
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In this study, pAKT levels were measured using western blot analysis. No significant 
difference in normalized level of pAKT to β-tubulin or in relative level of pAKT to total AKT 
was noted in the different treatment groups utilized. The treatment groups utilized included 
animals sacrificed 4 months and 9 months after total body radiation, HU or both. 
The MAPK pathway has been shown to be activated under the effect of radiation and 
stress conditions. Also, the MAPK pathway has been found to be upregulated in 10-30% of 
endometrial cancer. Like the PI3K pathway, activation of the MAPK pathway begins when a 
ligand binds to the membrane tyrosine kinase receptor, causing a downstream signaling cascade. 
pERK is one of the downstream effectors of the MAPK pathway. Phosphorylated ERK activates 
other proteins, which have an important role in cell growth and survival.  
In this study, the pERK level was measured using western blot analysis. No significant 
difference in pERK normalized to β-tubulin level or relative to total ERK were noted in the 
different treatment groups utilized. The treatment groups utilized included animals sacrificed 4 
months and 9 months after total body radiation, HU or both.  
The western blot analysis results were consistent with hematoxylin and eosin (H&E) 
stained uterine tissues. H&E staining of uterine tissues was performed to detect any possible 
abnormal changes at the gross morphological level under the effect of whole body radiation, 
microgravity, or both. The results of H&E stained uterine tissues show no morphological 
differences between the treatment groups in animals sacrificed 4 months and 9 months after total 
body radiation, HU or both.  
An IHC staining technique was also used to determine the expression level of AKT 
proteins in uterine tissues. Pan AKT primary antibody was used in the IHC staining technique. 
Pan AKT antibody detects the AKT proteins either in phosphorylated or non-phosphorylated 
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states. The results of IHC show mild diffuse staining of pan AKT in uterine tissues. No 
difference between treatment groups of animals sacrificed 4 months after total body radiation, 
HU or both was detected. IHC staining results for uterine tissues from animals sacrificed 9 
months after whole body radiation, unloading, or both show more intense staining of pan AKT 
compared to 4 months treatment groups.  
These results indicate that small dose 0.04 Gy (40 milliseivert) whole body gamma 
irradiation, HU, or both dose not induce the formation of uterine cancer formation. The fact that 
ionizing radiation causes cancer in humans has been documented. By 1902, the first radiation 
induced cancer was reported as skin cancer and the first report of radiation induced leukemia 
occurring in five radiation workers appeared in 1911 (Little 2000). These findings of radiation 
carcinogenesis were further supported by experimental studies of animal models and by long 
term follow up studies of atomic bomb survivors. These studies also documented the fact that 
radiation is a relatively weak carcinogen and mutagen compared with other chemicals, but its 
effect can be modulated significantly by other secondary factors (Beir 1990).  
Carcinogenesis is a multistep process which involves interaction of many external 
(chemical and physical) and endogenous factors such as age, sex, genetic background, and 
immunologic status (Beir 1990). The multistage model of carcinogenesis indicates that cancer 
formation requires 3 steps: initiation, promotion, and progression.  
The initiation process is irreversible. The radiation is considered an initiator of cancer. 
The ability of radiation to initiate cancer could be attributed to the wide spectrum of DNA 
lesions. It is well documented that the main target of radiation is DNA, which is damaged by the 
radiation. Radiation causes a wide spectrum of DNA lesions including damage to nucleotides, 
SSBs, and DSBs. DSBs are considered the primary lesion in the induction of gene mutation and 
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chromosomal aberrations (Mullenders et al. 2009). DSBs are repaired mainly via error prone 
NHEJ.  
The second process of carcinogenesis is promotion. This stage is reversible and requires 
stimulation of cell division. Ionizing radiation could be a promotor if given at high enough dose. 
Whereas the initiating agents, radiation, are carcinogenic by themselves if they were given in a 
large dose, promoting agents must be given repeatedly to over a long period of time, during 
which successive promotion may occur (Beir 1990; Little 2000). 
Progression is the third stage of carcinogenesis. This stage occurs when additional 
genetic alterations allow the cell to be invasive and metastatic. Ionizing radiation could progress 
cancer formation due to its ability to deactivate tumor suppressor genes. This multistage nature 
of carcinogenesis indicates that radiation is a contributing factor and by its interaction with 
various secondary factors can lead to cancer progression.  
Most studies investigating the relationship between radiation and cancer risk have looked 
at people who were exposed to high levels of radiation. It is more difficult to measure the risk of 
cancer after exposure to lower doses of radiation. Thus, whether low dose of ionizing radiation 
LDIR is a risk factor for cancer remains controversial (Mullenders 2009). A study done by 
Zhang et al. (2015) using a mouse model has revealed that a risk of mammary cancer from low 
dose radiation depends greatly on the genetic makeup of these mice. According to this study, 
cancer susceptibility is a complex process that depends on interaction between multiple factors, 
such as exposure to low dose radiation, genetic background, and the tumor microenvironment 
(immune, endocrine, and vascular system). They identified 13 genetic loci which contribute to 
tumor susceptibility when a mouse is exposed to radiation. Further research is needed to identify 
how these genetic loci affect cancer development. According to Zhang’s study, cancer risk from 
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exposure to low dose radiation differs among individuals. Therefore, one individual may have a 
higher risk to cancer after radiation exposure than another individual according to their genetic 
makeup. 
AKT, serine/threonine kinase, is considered one of the most critical regulators of cell 
cycle control, apoptosis, and metabolism. AKT is central to many human physiological 
processes, but an increase of function of AKT is linked to multiple diseases. An example of 
pathological involvement of PI3K pathway is a study done by Suman et al. (2012) investigated 
the effect of radiation exposure on mammary tissues. The researchers exposed mice to 2 Gy 
whole body gamma radiation. The results showed increase incidence of breast cancer. According 
to this study, radiation lead to increase expression of estrogen which binds to estrogen receptor 
alpha (ERα) resulting in activation of PI3K pathway. Western blot analysis of the uterine tissues 
in our study shows a clear band for pAKT in all treatment groups without significant differences. 
AKT plays a physiological role in uterine tissue regulating factors related to cell death and 
proliferation, such as embryo implantation, decidualization, and menstruation (Fabi and Asselin 
2014). 
ERK proteins play a significant role not only in pathological processes but also in 
different physiological processes such as proliferation, differentiation and development (Shaul 
and Seger 2007). The physiological role of the PI3K and MAPK pathways in the uterus involve 
functions related to tissues remodeling that occur during the menstrual cycle and during embryo 
implantation. Cell migration is an example of physiological processes used by cells during 
several processes such as wound healing. The endometrium is plastic tissue which undergoes 
adaptive reactions to the physiological changes that occur in different phases of the 
menstrual/estrous cycle and during embryo implantation (Gentilini et al. 2007). When 
endometrial tissue loss occurs during menstruation, endometrial cell growth, angiogenesis, and 
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cell migration act together to reestablish organ integrity and refill the space created by tissue 
loss. According to the study of Gentilini et al. (2007) MAPK and PI3K pathways are activated in 
response to growth factors and cytokines and have important role in cell migration and growth 
during endometrial remodeling. These proteins are expressed normally in uterine tissues in order 
to perform necessary physiological functions. This could explain the visible bands of pERK and 
pAKT in the western blots of our uterine tissues.  
IHC staining results showed more intense staining for AKT proteins in animals sacrificed 
9 months post treatment compared to animals sacrificed 4 months post whole body radiation, 
microgravity, or both. This may indicate higher level of AKT proteins in 9 months samples 
compared to 4 months samples. Animals sacrificed 9 months post whole body irradiation, 
microgravity, or both may live enough time to show cellular changes after treatment. This may 
indicate higher cellular activity in 9 months treatment groups which could be indicative for 
abnormal changes or hyperplasia in uterine tissues. Further research using more quantitative 
methods is needed to explain this increase. 
Linear energy transfer (LET) is the energy transferred per unit length of track. Low LET 
radiation travel longer distance through matter and deposits less energy. High LET radiation 
deposits large amount of radiation in a small distance. So, high LET radiation causes more 
cellular damage than low LET radiation (Cucinotta and Durante 2006). Spaceflight radiation is 
considered high LET, while X-rays and gamma rays are low LET radiation. The main health 
concerns of astronaut’s health are exposure to space radiation. Space radiation includes high 
charge and energy protons (HZE) and secondary radiation produced by nuclear reaction in space 
craft walls or in tissues. The possible mission to mars could result in whole body radiation dose 
of about 1 Sievert or more.  
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Studies have shown that high LET radiation produces different DNA lesions and complex 
breaks compared with low LET radiation (Cucinotta and Durante 2006). Complex damage 
occurs within a localized region of DNA making the repair more difficult. This will cause more 
complex chromosomal rearrangement which may lead to cancer formation or cell death. Being 
limited in its ability to accurately simulate the radiation component of spaceflight and therefore, 
although we did not see any incidence of uterine cancer, this would not preclude astronauts 
exposed to higher energy radiation from developing uterine cancer. Some future aims in working 
on this project include using higher level of radiation dose and studying the effect of radiation, 
microgravity, or both directly on the PTEN and KRAS genes. 
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